一个极为罕见的肺上皮质血栓内皮质瘤的病例
Xi Chen1, Yun Wang2, Guowei Che2
1Department of Integrated Care Management Center, West-China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Thoracic cancer
|July 25, 2023
概括
皮质状血管内皮瘤 (EHE) 是一种罕见的血管瘤. 这份报告详细介绍了一例肺部EHE病例,强调了诊断方面的挑战和需要更多的研究.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 胸部外科手术 胸部外科手术
背景情况:
- 皮质状血管内皮瘤 (EHE) 是一种罕见的血管瘤,起源于内皮细胞.
- 它的特点是低到中度的分化和转移的潜力.
- EHE的发生率不到百万分之一.
研究的目的:
- 报告一个罕见的肺上皮质血管内皮瘤 (EHE) 病例.
- 审查EHE的临床和病理特征.
- 讨论这种罕见瘤的诊断挑战.
主要方法:
- 一个患有肺部EHE的病人的病例报告.
- 通过视频辅助胸部手术进行手术切除 (左上叶切除).
- 关于EHE的临床和病理方面的文献综述.
主要成果:
- 成功地彻底除了肺部的EHE病变.
- 这项研究强调了手术前诊断EHE的困难.
- 这些发现凸显了肺部EHE的罕见性和诊断挑战.
结论:
- 肺上皮质性血管内皮瘤 (EHE) 呈现出诊断上的困难.
- 需要更多的病例报告来改善手术前诊断.
- 手术干预对于彻底去除病变至关重要.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
227
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
227
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
201
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201


